FR2295741A1 - Derives de la pyridoxine, leur procede de preparation et leur application - Google Patents

Derives de la pyridoxine, leur procede de preparation et leur application

Info

Publication number
FR2295741A1
FR2295741A1 FR7531075A FR7531075A FR2295741A1 FR 2295741 A1 FR2295741 A1 FR 2295741A1 FR 7531075 A FR7531075 A FR 7531075A FR 7531075 A FR7531075 A FR 7531075A FR 2295741 A1 FR2295741 A1 FR 2295741A1
Authority
FR
France
Prior art keywords
hypolipaemic
pyridoxine
amino acids
phosphate salts
hypocholesterolaemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7531075A
Other languages
English (en)
Other versions
FR2295741B1 (fr
Inventor
Rolf Eurich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Steigerwald Arzneimittelwerk GmbH
Original Assignee
Steigerwald Arzneimittelwerk GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk GmbH filed Critical Steigerwald Arzneimittelwerk GmbH
Publication of FR2295741A1 publication Critical patent/FR2295741A1/fr
Application granted granted Critical
Publication of FR2295741B1 publication Critical patent/FR2295741B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
FR7531075A 1974-12-28 1975-10-10 Derives de la pyridoxine, leur procede de preparation et leur application Granted FR2295741A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2461742A DE2461742C2 (de) 1974-12-28 1974-12-28 Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FR2295741A1 true FR2295741A1 (fr) 1976-07-23
FR2295741B1 FR2295741B1 (fr) 1979-09-14

Family

ID=5934705

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7531075A Granted FR2295741A1 (fr) 1974-12-28 1975-10-10 Derives de la pyridoxine, leur procede de preparation et leur application

Country Status (2)

Country Link
DE (1) DE2461742C2 (fr)
FR (1) FR2295741A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282696A2 (fr) * 1987-02-18 1988-09-21 Steigerwald Arzneimittelwerk Gmbh Emploi de dérivés de pyridoxine pour la prophylaxie et le traitement de l'hyperlipémie et de l'athérosclérose
EP0458287A2 (fr) * 1990-05-25 1991-11-27 Steigerwald Arzneimittelwerk Gmbh Utilisation de magnésium-pyridoxal-5'-phosphate-glutaminate pour la prévention des maladies résultant des lésions vasculaires

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6228858B1 (en) 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US5744451A (en) 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
WO2000022094A2 (fr) * 1998-10-09 2000-04-20 Kansas University Medical Center Procede permettant d'inhiber la modification oxydative des proteines
ES2250112T3 (es) 1999-03-08 2006-04-16 Medicure Inc. Analogos de piridoxal para el tratamiento de trastornos causados por carencia de vitamina b6.
CA2376029A1 (fr) 1999-07-13 2001-01-18 Medicure Inc. Traitement du diabete et des pathologies associees
WO2001013900A2 (fr) 1999-08-24 2001-03-01 Medicure International Inc. Traitement des pathologies cardio-vasculaires et connexes
ATE293119T1 (de) 2000-02-29 2005-04-15 Medicure Int Inc Cardioprotektive phosphonate
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
EP1299358B1 (fr) 2000-07-07 2007-06-13 Medicure International Inc. Analogues de pyridoxine et de pyridoxal comme agents de therapie cardio-vasculaire
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
AU2005304220A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7375112B2 (en) * 2005-01-05 2008-05-20 Medicure International Inc. Compounds and methods for regulating triglyceride levels
WO2006087232A1 (fr) * 2005-02-17 2006-08-24 Instituto Del Metabolismo Celular, S.L. Acide l-aspartique destine au traitement de problemes lies au metabolisme des graisses ou du glucose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282696A2 (fr) * 1987-02-18 1988-09-21 Steigerwald Arzneimittelwerk Gmbh Emploi de dérivés de pyridoxine pour la prophylaxie et le traitement de l'hyperlipémie et de l'athérosclérose
EP0282696A3 (en) * 1987-02-18 1989-06-14 Ulrich Dr. Speck Use of pyridoxine derivatives in the prophylaxis and treatment of hyperlipemia and atherosclerosis
EP0458287A2 (fr) * 1990-05-25 1991-11-27 Steigerwald Arzneimittelwerk Gmbh Utilisation de magnésium-pyridoxal-5'-phosphate-glutaminate pour la prévention des maladies résultant des lésions vasculaires
EP0458287A3 (en) * 1990-05-25 1992-04-08 Steigerwald Arzneimittelwerk Gmbh Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions

Also Published As

Publication number Publication date
FR2295741B1 (fr) 1979-09-14
DE2461742C2 (de) 1983-01-27
DE2461742A1 (de) 1976-07-08

Similar Documents

Publication Publication Date Title
FR2295741A1 (fr) Derives de la pyridoxine, leur procede de preparation et leur application
GB1527191A (en) Process for the production of n-phosphonomethyl glycine
GB1377687A (en) Aminoalkyl esters of perfluoroalkyl-terminated alkylene thioalkanoic acids and derivatives thereof
DE3867445D1 (de) Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
SE7710114L (sv) 7-acylamino-8-oxo-3-oxa-1-azabicyklo(4.2.0)oktan-2-karbonsyraderivat
GB1456627A (en) Pyridobenzodiazepinones
BG34036A3 (en) A method of obtaining propargyl- 2- phenylamino- imidazolines- (2) and their acid salts
IL51272A (en) Production of 3,3-dimethyl-2-oxo-butyric acid salts
ATE35994T1 (de) Dihydroxyalkandiphosphonsaeuren.
ATE9328T1 (de) 2-nitro-5-(substituiertes phenoxy) phenylalkanon- oxim- und -imin-derivate mit herbizider wirkung.
ES435003A1 (es) Un proceso para la produccion de un compuesto cefem.
CH609669A5 (en) Process for the preparation of metformin clofibrate
ES444508A1 (es) Procedimiento para la preparacion de florogucina.
NL7410333A (en) 2'-Aminoethyl 3,5'-dimethyl (thio)benzoates - as anti-ulcerogenic agents
FR2276035A1 (fr) Nouveaux derives de l'indane
ZA83851B (en) Carbacyclins, process for the preparation thereof, and use thereof as medicinal agents
ES8604556A1 (es) Procedimiento para preparar derivados de flaveno y tioflave-no
GB1364615A (en) Preparation of n -diethylaminoethyl - 2 - methoxy- 5 - methyl sulphonylbenzamide
EP0147152A3 (en) Improvements in or relating to novel salts of dimeric indole-dihydroindole alkaloids
FR2278326A1 (fr) Derives de l'acide 3,5 dimethyl-benzoique
FR2298321A1 (fr) Medicament a base de cinnarizine et d'acides phenoxyalcane-carboxyliques ou de leurs derives,
GB1355005A (en) Process for making betaines
FR2258186A1 (en) 10-((4-hydroxyethylpiperidino)alkyl)-phenothiazines - with antiemetic activity
FR2290907A2 (fr) Nouveaux derives de la phenothiazine, leur preparation et les compositions qui les contiennent
ES8601695A1 (es) Procedimiento para la preparacion de compuestos de pteridina